Henry Schein (NASDAQ:HSIC) Posts Earnings Results, Beats Expectations By $0.09 EPS

Henry Schein (NASDAQ:HSIC) released its quarterly earnings results on Tuesday. The company reported $1.10 EPS for the quarter, beating the consensus estimate of $1.01 by $0.09, Briefing.com reports. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.21 billion. Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The business’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.21 EPS. Henry Schein updated its FY24 guidance to $5.00 to $5.16 EPS.

Henry Schein Stock Down 0.2 %

NASDAQ HSIC traded down $0.15 during trading hours on Friday, hitting $73.29. 61,347 shares of the company were exchanged, compared to its average volume of 1,098,647. The company has a 50 day moving average of $72.95 and a two-hundred day moving average of $72.35. The company has a quick ratio of 1.00, a current ratio of 1.67 and a debt-to-equity ratio of 0.45. The firm has a market cap of $9.42 billion, a price-to-earnings ratio of 23.31, a PEG ratio of 1.68 and a beta of 0.87. Henry Schein has a 52-week low of $60.01 and a 52-week high of $82.63.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. Leerink Partnrs reaffirmed a “market perform” rating on shares of Henry Schein in a research note on Monday, February 26th. JPMorgan Chase & Co. increased their target price on shares of Henry Schein from $82.00 to $88.00 and gave the stock an “overweight” rating in a research note on Wednesday, March 6th. SVB Leerink assumed coverage on shares of Henry Schein in a report on Monday, February 26th. They issued a “market perform” rating and a $78.00 price objective on the stock. UBS Group dropped their target price on shares of Henry Schein from $82.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday. Finally, Piper Sandler upped their price target on Henry Schein from $78.00 to $86.00 and gave the stock an “overweight” rating in a research note on Monday, February 26th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and five have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $81.73.

Insider Buying and Selling

In other news, CEO Bradford C. Connett sold 6,430 shares of the firm’s stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the sale, the chief executive officer now directly owns 73,108 shares in the company, valued at approximately $5,430,462.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, Vice Chairman James P. Breslawski sold 2,907 shares of the firm’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $74.37, for a total transaction of $216,193.59. Following the transaction, the insider now directly owns 209,562 shares in the company, valued at $15,585,125.94. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Bradford C. Connett sold 6,430 shares of the firm’s stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the transaction, the chief executive officer now directly owns 73,108 shares in the company, valued at $5,430,462.24. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.